Clearside’s innovative SCS Microinjector is being used in commercial ophthalmic products and promising clinical development programs by Aura Biosciences, Bausch + Lomb, BioCryst Pharmaceuticals, ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

FDA designation highlights the potential of PMN310 to deliver a more targeted approach to treating Alzheimer’s Disease ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

Tamarack Biotics’ TruActive process targets pathogens with UV light while keeping the milk’s enzymes and proteins intact.

Microplastics used to sound like a distant environmental issue, but they're showing up in more places than you'd expect, ...

Enrollment in FURVENT was completed in Q1 2025 Firmonertinib received FDA Breakthrough Therapy Designation in this patient population NEWTOWN SQUARE, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- ArriVent ...

Otsuka and Lundbeck’s data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD, according ...

In light of recent patient deaths, the FDA has also revoked its platform designation for Sarepta’s AAVrh74 technology. The ...

Study shows erythritol adversely affects brain microvascular cells, increasing oxidative stress and impairing nitric oxide ...

Over 67,000 cases of “Power Stick” roll‑on deodorant recalled by A.P. Deauville due to cGMP violations. Three variants are ...

FDA issues a complete response letter for glofitamab's second-line DLBCL indication, highlighting ongoing scrutiny in ...